Swiss stocks remained in the green on Wednesday, with the Swiss Market Index up 0.20% at closing, as investors assessed the latest company releases and geopolitical developments in the Middle East.
"The US had earlier warned of retaliation for Iranian missiles launched against a US military base in Jordan over the weekend and [President Donald] Trump posted that if 'Iran retaliates for this very justified attack, they will be hit again at a much harder and higher level'. Iran then responded with what it called a 'decisive operation' against US bases in the region, with local media reporting more missile interceptions in Jordan," according to analysts at Deutsche Bank Research. "As a reminder, the renewed escalation has come as Iran has tried to target ships transiting the Strait of Hormuz by going dark, with the US in turn seeking to degrade Iran's ability to disrupt these flows."
Back home, the Swiss Federal Council launched a consultation on Switzerland's agricultural policy from 2030 onward as part of efforts to bolster food security in the country, with proposed measures including improving crop protection and providing additional funding for sustainable technologies. The consultation will run until Dec. 8.
Meanwhile, the Swiss government appointed Christoph Ammann as president of the Swiss National Bank's (SNBN.SW) Bank Council, succeeding Barbara Janom Steiner, effective May 1, 2027. Marc Mächler was named vice president.
Over to corporates, Nestlé (NESN.SW) agreed to sell its mainstream vitamins, minerals and supplements business to US private equity firm Yellow Wood Partners for $1 billion. The transaction, which is anticipated to complete by the first half of 2027, covers seven brands and the associated private-label supplements business in the US, along with dedicated manufacturing, packaging, warehousing and distribution operations. The Swiss consumer goods giant's shares rose 0.15% at closing.
"This is another important step in the strategic transformation of our portfolio. We are focusing our resources where we have the strongest competitive advantage. With Nestlé's strong innovation and brand-building capabilities, we are well positioned for growth in the premium, science-led [vitamins, minerals and supplements] space, where brands such as Solgar and Pure Encapsulations continue to perform strongly," Nestlé Chief Executive Officer Philipp Navratil said.
Novartis (NOVN.SW) will discontinue small-volume biologics production at its Kleinbasel site in Switzerland by 2027-end, potentially affecting 130 jobs, and relocate laboratories supporting biological cell banks, analytical testing and technical development activities there to its campus in Basel by the end of 2028. The move is part of the Swiss pharmaceutical major's wider plan to establish a new biologics technical development center on the Basel campus. The stock closed the trading session 0.27% higher.